Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

654
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
654
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.7K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.7K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

347
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
347
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

3.3K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reducing frailty in frail people with multiple sclerosis: Feasibility of a 6-week multimodal exercise training program.

PloS one·2026
Same author

Reexamining the Role of Amyloid β Clearance from the Brain: Exporting Labile Iron from the Interstitial Fluid Performs a Protective Function.

International journal of molecular sciences·2026
Same author

Frailty, Disability, and Comorbidity in Multiple Sclerosis: Overlap and Distinct Associations with Quality of Life and Falls.

Multiple sclerosis and related disorders·2026
Same author

Frailty and its association with mental health and quality of life in multiple sclerosis: A cross-sectional study.

Therapeutic advances in chronic disease·2026
Same author

Multiscale modeling of drug-induced liver injury from organ to lobule.

NPJ digital medicine·2025
Same author

Comparison of gait parameters and chronic lower body pain in people with multiple sclerosis.

Multiple sclerosis and related disorders·2025
Same journal

Brief digital narrative intervention for adolescent depression, anxiety, and insomnia during academic stress: a cluster randomized controlled trial.

BMC medicine·2026
Same journal

Effect of Vitamin C on bleeding and pain after kidney biopsy: a randomized controlled trial.

BMC medicine·2026
Same journal

Impact of gestational diabetes on future diabetic retinopathy and microvascular complications: a nationwide cohort study.

BMC medicine·2026
Same journal

Convergence of schizophrenia risk genes on CALN1 disrupts human forebrain development and drives core psychotic behaviors including hallucination-like perception.

BMC medicine·2026
Same journal

Efficacy of leflunomide in active Takayasu arteritis: a randomized double-blind placebo-controlled trial subtitle: Takayasu arteritis clinical trial in China (TACTIC).

BMC medicine·2026
Same journal

Refined AI-ASPECTS with modified atlas and lesion-load thresholds: advancing acute ischemic stroke imaging and prognostic prediction.

BMC medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 8, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.8K

Aspirin and multiple sclerosis.

Sheila Tsau1, Mitchell R Emerson2, Sharon G Lynch3

  • 1Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA. sstsau@yahoo.com.

BMC Medicine
|July 1, 2015
PubMed
Summary
This summary is machine-generated.

Aspirin may offer benefits for multiple sclerosis (MS) patients by reducing cardiovascular risks and potentially aiding remyelination. However, risks like hemorrhagic stroke and mitochondrial inhibition require careful consideration for MS patients.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K

Related Experiment Videos

Last Updated: Apr 8, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

12.8K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.1K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Multiple sclerosis (MS) patients exhibit increased risk for cardiovascular events like venous thromboembolism and ischemic strokes.
  • Aspirin is a common medication for cardiovascular event prevention.
  • The potential benefits and risks of aspirin in MS patients are not fully understood.

Purpose of the Study:

  • To evaluate the potential benefits of aspirin in mitigating cardiovascular risks for multiple sclerosis patients.
  • To explore aspirin's potential role in addressing MS-specific pathological mechanisms, such as inflammation and remyelination.
  • To assess the risks associated with aspirin use in multiple sclerosis, including hemorrhagic stroke and mitochondrial function.

Main Methods:

  • Review of existing studies on aspirin's cardiovascular effects.
  • Analysis of research on aspirin's impact on inflammation and mitochondrial function.
  • Examination of experimental data on aspirin's effect on oligodendrocyte precursor cells.

Main Results:

  • Aspirin may reduce cardiovascular risks in MS patients, particularly in subgroups with limited mobility or antiphospholipid antibodies.
  • Aspirin demonstrated potential in experimental models to promote remyelination by affecting oligodendrocyte precursors.
  • Concerns exist regarding aspirin's increased risk of hemorrhagic stroke and potential inhibition of mitochondrial complex I activity, which is already impaired in MS.

Conclusions:

  • Aspirin presents a complex risk-benefit profile for multiple sclerosis patients.
  • Further research is warranted to determine optimal use cases and safety in specific MS populations.
  • Aspirin's potential to reduce cardiovascular events and aid remyelination must be weighed against its associated risks.